66315-23-9

Usage

Uses

Used in Pharmaceutical Research:
ETHYL 3-AMINO-4-(METHYLAMINO)BENZOATE is used as a building block in pharmaceutical research for the preparation of various pharmaceuticals and bioactive compounds. Its unique structure and functional groups contribute to the development of new drugs with potential therapeutic effects.
Used in Organic Synthesis:
In the field of organic synthesis, ETHYL 3-AMINO-4-(METHYLAMINO)BENZOATE is utilized as a key intermediate for the synthesis of complex organic molecules. Its presence of reactive functional groups allows for various chemical reactions, facilitating the creation of a wide range of organic compounds.
Used in Anti-inflammatory Applications:
ETHYL 3-AMINO-4-(METHYLAMINO)BENZOATE has been studied for its potential anti-inflammatory properties. It is used as a therapeutic agent in the development of treatments for inflammatory conditions, aiming to reduce inflammation and alleviate associated symptoms.
Used in Anti-cancer Applications:
ETHYL 3-AMINO-4-(METHYLAMINO)BENZOATE has also been investigated for its anti-cancer properties. ETHYL 3-AMINO-4-(METHYLAMINO)BENZOATE is used as a potential anti-cancer agent, with the aim of developing new cancer treatments that target and inhibit the growth and proliferation of cancer cells.
Used in Drug Development:
In the drug development industry, ETHYL 3-AMINO-4-(METHYLAMINO)BENZOATE is used as a precursor in the synthesis of new drug candidates. Its unique chemical structure and potential biological activities make it a valuable component in the discovery and development of novel therapeutic agents.

InChI:InChI=1/C10H14N2O2/c1-3-14-10(13)7-4-5-9(12-2)8(11)6-7/h4-6,12H,3,11H2,1-2H3

Upstream product

• 71254-71-2 ethyl 4-(methylamino)-3-nitrobenzoate 
• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 367-80-6 ethyl 4-fluoro-3-nitrobenzoate 
• 16588-16-2 ethyl 4-chloro-3-nitrobenzoate 

Downstream Products

• 53484-19-8 ethyl 1-methyl-1H-benzo[d]imidazole-5-carboxylate 
• 91332-09-1 ethyl 2-amino-1-methyl-1H-benzo[d]imidazole-5-carboxylate 
• 916587-19-4 C₁₇H₁₇N₃O 
• 916587-20-7 C₁₇H₁₉N₃ 
• 71254-70-1 ethyl 1,2-dimethyl-1H-benzimidazole-5-carboxylate 
• 115576-91-5 (1-methyl-1H-benzimidazol-5-yl)methanol 
• 53484-17-6 1-methyl-1H-benzo[d]imidazole-5-carboxylic acid 
• 121732-18-1 2,6-bis(bromomethyl)-3-methylimidazo<4,5-g>quinazoline-4,8,9(3H,7H)-trione 

Relevant academic research and scientific papers

HMOX1 inducers

The present invention is related to compounds of structure (I) as heme oxygenase 1 (HMOX 1) inducers. The present invention is also related a method of controlling the activity or the amount, or both the activity and the amount, of heme-oxygenase 1 in a mammalian subject. The definitions of the variables are provided herein.

HETEROCYCLIC COMPOUND AND p27Kip1 DEGRADATION INHIBITOR

A novel heterocyclic compound or a salt thereof useful for selectively inhibiting the degradation of p27Kip1 is provided. The compound or the salt thereof is represented by the following formula (1): wherein A represents an alkyl group, a cycloalkyl group, an aryl group or a heterocyclic group, the group A may have a substituent; the ring B represents a 5- to 8-membered monocyclic heterocyclic ring or a condensed ring containing the monocyclic heterocyclic ring, the ring B may have a substituent; the ring C represents an aromatic ring, the ring C may have a substituent; L represents a linker comprising a main chain having 3 to 5 atoms selected from the group consisting of a carbon atom, a nitrogen atom, an oxygen atom and a sulfur atom, wherein at least one atom in the main chain is a hetero atom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, the linker L may have a substituent; and n is 0 or 1.